Abstract
As an important economy branch dealing with the allocation of health-related resource, health economics mainly covers studies concentrating on issues related to multiple medical actions and disease researches concerning efficiency, effectiveness, value, and behavior in the production and consumption of both health and health care. The focus of this chapter is to give a brief introduction on the notions and definitions of the modern health economies, as well as the general containment of the works underlying this specific notion of study. Two commonly seen neuropsychological or neurodegenerative diseases (Parkinson’s disease and Alzheimer’s disease), both inconvertible and with relatively lengthy process, are specifically described in order to illustrate the work of health economies in a well-understood manner. The calculation of the economic burden and the process of financial evaluation of the two examples would help demonstrate the importance of economic planning of health problems.
Similar content being viewed by others
References
Allegri RF, Butman J, Arizaga RL, Machnicki G, Serrano C, Taragano FE, Sarasola D, Lon L. Economic impact of dementia in developing countries: an evaluation of costs of Alzheimer-type dementia in Argentina. Int Psychogeriatr. 2007;19(4):705–18.
Anderson GF, Chalkidou K. Spending on medical care: more is better? JAMA. 2008;299(20): 2444–5.
Bragaglia P, O’Brien L. Chronic disease management: the primary care perspective. Healthc Pap. 2007;7(4):26–8; discussion 68–70.
Dodel RC, Haacke C, Zamzow K, Paweilik S, Spottke A, Rethfeldt M, Siebert U, Oertel WH, Schoffski O, Back T. Resource utilization and costs of stroke unit care in Germany. Value Health. 2004;7(2):144–52.
Durrani H. Healthcare and healthcare systems: inspiring progress and future prospects. mHealth. 2016;2:3.
Fan VY, Savedoff WD. The health financing transition: a conceptual framework and empirical evidence. Soc Sci Med. 2014;105:112–21.
Fan J, Dawson TM, Dawson VL. Cell death mechanisms of neurodegeneration. Adv Neurobiol. 2017;15:403–25.
Garibaldi P, Martins JO, van Ours J. Ageing, health, and productivity: the economics of increased life expectancy. Oxford: Oxford University Press; 2010.
Gooch CL, Pracht E, Borenstein AR. The burden of neurological disease in the United States: a summary report and call to action. Ann Neurol. 2017;81(4):479–84.
Guerriere DN, Tranmer JE, Ungar WJ, Manoharan V, Coyte PC. Valuing care recipient and family caregiver time: A comparison of methods. International Journal of Technology Assessment in Health Care. 2008;24(01):52–9.
Hall RE, Jones CI. The value of life and the rise in health spending. Q J Econ. 2007;122(1):39–72.
Harrow BS, Mahoney DF, Mendelsohn AB, Ory MG, Coon DW, Belle SH, Nichols LO. Variation in cost of informal caregiving and formal-service use for people with Alzheimer’s desease. American Journal of Alzheimer’s Disease & Other Dementias. 2004;19(5):299–308.
Jia J, Zhou A, Wei C, Jia X, Wang F, Li F, Wu X, Mok V, Gauthier S, Tang M, Chu L, Zhou Y, Zhou C, Cui Y, Wang Q, Wang W, Yin P, Hu N, Zuo X, Song H, Qin W, Wu L, Li D, Jia L, Song J, Han Y, Xing Y, Yang P, Li Y, Qiao Y, Tang Y, Lv J, Dong X. The prevalence of mild cognitive impairment and its etiological subtypes in elderly Chinese. Alzheimers Dement. 2014;10(4):439–47.
Jonsson L, Eriksdotter Jonhagen M, Kilander L, Soininen H, Hallikainen M, Waldemar G, Nygaard H, Andreasen N, Winblad B, Wimo A. Determinants of costs of care for patients with Alzheimer’s disease. Int J Geriatr Psychiatry. 2006;21(5):449–59.
Kowal SL, Dall TM, Chakrabarti R, Storm MV, Jain A. The current and projected economic burden of Parkinson’s disease in the United States. Mov Disord. 2013;28(3):311–8.
Langa KM, Larson EB, Crimmins EM, Faul JD, Levine DA, Kabeto MU, Weir DR. A comparison of the prevalence of dementia in the United States in 2000 and 2012. JAMA Intern Med. 2017;177(1):51–8.
Liu N, Zhang J, Guo L. Alzheimer’s disease epidemiological situation. J Liaoning Univ Tradit Chin Med. 2011;1:35–6.
Manes F. The huge burden of dementia in Latin America. Lancet Neurol. 2016;15(1):29.
Morris S, Patel N, Baio G, Kelly L, Lewis-Holmes E, Omar RZ, Katona C, Cooper C, Livingston G. Monetary costs of agitation in older adults with Alzheimer’s disease in the UK: prospective cohort study. BMJ Open. 2015;5(3):e007382.
Muangpaisan W, Hori H, Brayne C. Systematic review of the prevalence and incidence of Parkinson’s disease in Asia. J Epidemiol. 2009;19(6):281–93.
Park M, Sung M, Kim SK, Kim S, Lee DY. Multidimensional determinants of family caregiver burden in Alzheimer’s disease. Int Psychogeriatr. 2015;27(8):1355–64.
Prince M. Care arrangements for people with dementia in developing countries. Int J Geriatr Psychiatry. 2004;19(2):170–7.
Rajput AH, Offord KP, Beard CM, Kurland LT. Epidemiology of parkinsonism: incidence, classification, and mortality. Ann Neurol. 1984;16(3):278–82.
Sorenson C, Drummond M, Bhuiyan Khan B. Medical technology as a key driver of rising health expenditure: disentangling the relationship. Clinicoecon Outcomes Res. 2013;5:223–34.
von Campenhausen S, Bornschein B, Wick R, Botzel K, Sampaio C, Poewe W, Oertel W, Siebert U, Berger K, Dodel R. Prevalence and incidence of Parkinson’s disease in Europe. Eur Neuropsychopharmacol. 2005;15(4):473–90.
Wang G, Cheng Q, Zheng R, Tan YY, Sun XK, Zhou HY, Ye XL, Wang Y, Wang Z, Sun BM, Chen SD. Economic burden of Parkinson’s disease in a developing country: a retrospective cost analysis in Shanghai, China. Mov Disord. 2006;21(9):1439–43.
Wang G, Cheng Q, Zhang S, Bai L, Zeng J, Cui PJ, Zhang T, Sun ZK, Ren RJ, Deng YL, Xu W, Wang Y, Chen SD. Economic Impact of Dementia in Developing Countries: An Evaluation of Alzheimer-Type Dementia in Shanghai, China. Journal of Alzheimer’s Disease. 2008;15(1):109–15.
Wang J, Xiao LD, He GP, De Bellis A. Family caregiver challenges in dementia care in a country with undeveloped dementia services. J Adv Nurs. 2014;70(6):1369–80.
Williams A. Health and Economics. Palgrave Macmillan, London. 1987.
Wong YC, Leung J. Long-term care in China: issues and prospects. J Gerontol Soc Work. 2012; 55(7):570–86.
Wu C, Gao L, Chen S, Dong H. Care services for elderly people with dementia in rural China: a case study. Bull World Health Organ. 2016;94(3):167–73.
Yang Z, Lin PJ, Levey A. Monetary costs of dementia in the United States. N Engl J Med. 2013; 369(5):489.
Zencir M, Kuzu N, Beser NG, Ergin A, Catak B, Sahiner T. Cost of Alzheimer’s disease in a developing country setting. Int J Geriatr Psychiatry. 2005;20(7):616–22.
Zhang Y, Xu Y, Nie H, Lei T, Wu Y, Zhang L, Zhang M. Prevalence of dementia and major dementia subtypes in the Chinese populations: a meta-analysis of dementia prevalence surveys, 1980–2010. J Clin Neurosci. 2012;19(10):1333–7.
Zhang H, Loi SM, Zhou S, Zhao M, Lv X, Wang J, Wang X, Lautenschlager N, Yu X, Wang H. Dementia literacy among community-dwelling older adults in urban China: a cross-sectional study. Front Public Health. 2017;5:124.
Zhu CW, Scarmeas N, Torgan R, Albert M, Brandt J, Blacker D, Sano M, Stern Y. Clinical features associated with costs in early AD: baseline data from the Predictors Study. Neurology. 2006; 66(7):1021–8.
Zou YM, Liu J, Tian ZY, Lu D, Zhou YY. Systematic review of the prevalence and incidence of Parkinson’s disease in the People’s Republic of China. Neuropsychiatr Dis Treat. 2015;11:1467–72.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Cui, Hl., Wang, G. (2020). Health Economics for Neuropsychological Diseases in China. In: Riederer, P., Laux, G., Mulsant, B., Le, W., Nagatsu, T. (eds) NeuroPsychopharmacotherapy. Springer, Cham. https://doi.org/10.1007/978-3-319-56015-1_17-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-56015-1_17-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-56015-1
Online ISBN: 978-3-319-56015-1
eBook Packages: Springer Reference MedicineReference Module Medicine